American Healthcare REIT, Inc. (AHR) Stock Price & Analysis

American Healthcare REIT, Inc. (AHR) closed at USD 52.94 on Thursday, October 29, 2026, up 2.80% on the day. The US market is currently closed (after-hours); this is not a live price.

The prior close was USD 51.5; the Oct 29, 2026 session ranged USD 51.56–53.11 on volume of 3,845,373 shares. Market capitalization is $11.54B, with a 52-week range of USD 44.41–58.7 (NYQ). Source: Nexqual, retrieved October 29, 2026 at 20:30 UTC.

Also available as compact Markdown for AI agents: nexqual.com/AHR.md

Key facts (AHR)

• Last four reported quarters (through Jun 30, 2026): revenue $2.50B, net income $121M (4.8% margin) (SEC filings).
• Valuation: P/E 95.4x (avg 112.5x at the last 1 fiscal year-ends).
• Earnings quality: non-operating income -$61.7M vs operating income $480M over the last four quarters; P/E excluding non-operating income ≈63.2x (estimate: non-operating income taxed at the company's 0% effective rate).
• Analysts: Buy (mean 1.63 on a 1–5 scale) (16 analysts), mean target USD 63.69 (range 55–74).
• Next earnings: 2026-11-05, EPS estimate USD 0.16, revenue estimate $725M.

Financials (SEC 10-K; TTM = last four 10-Q/10-K quarters) (AHR)

Fiscal years end Dec. EPS is split-adjusted.

Valuation (price ÷ last four quarters, through Jun 30, 2026) (AHR)

P/E 95.4x · P/E ex non-operating (est.) ≈63.2x · P/S 4.6x · P/B 3.1x · Earnings yield 1.05% · Dividend yield (paid, TTM) 1.55%

P/E at fiscal year-ends: Dec 2025 112.5x.

Analysts (AHR)

Consensus Buy (mean 1.63 on a 1–5 scale), 16 analysts; mean target USD 63.69 (low 55, high 74).

Rating changes, last 120 days:

AHR earnings history and stock reaction

EPS as reported against the analyst consensus before the release; surprise uses the cent-rounded figures shown (in dollars when EPS and consensus have opposite signs). Stock reaction = close before the results to close after (the first close following a release after the bell or before the open).

AHR recent SEC filings (last 120 days)

Source: SEC EDGAR. Quotes are the opening words of each item as filed; each form links to the filing. Insider Form 4 filings are listed in the insider sections.

AHR analyst estimates and revisions

Key Statistics (as of October 29, 2026 at 20:30 UTC)

Analyst Ratings (AHR)

Wall Street analysts rate AHR "Buy" based on 16 analysts, with a mean price target of USD 63.69 (range USD 55–74), per Nexqual as of October 29, 2026 at 20:30 UTC.

Earnings (AHR)

Recent Earnings History

Source: Nexqual, October 29, 2026 at 20:30 UTC.

Financials & Fundamentals (AHR)

Source: Nexqual, October 29, 2026 at 20:30 UTC.

Financial Health Score (AHR)

Nexqual rates American Healthcare REIT, Inc.'s overall financial health "Mixed" across five dimensions, as of October 29, 2026 at 20:30 UTC.

Ownership (AHR)

Source: Nexqual, October 29, 2026 at 20:30 UTC.

From American Healthcare REIT, Inc.'s Latest SEC 10-K Filing (filed 2026-02-27)

Key Strengths & Strategy (as disclosed to the SEC)

• We have built a fully-integrated management platform, with approximately 121 employees as of December 31, 2025, that operates clinical healthcare properties throughout the United States, and in the United Kingdom and the Isle of Man.
• We own and operate our integrated senior health campuses, or ISHC, and senior-housing operating properties, or SHOP, utilizing the structure permitted by the REIT Investment Diversification and Empowerment Act of 2007, which is commonly referred to as a "RIDEA" structure.
• We seek to acquire properties where the future expected capital needs can be reasonably projected in a manner that would enable us to meet our objectives.
• We seek to acquire properties where the current and projected cash flows, including the potential for appreciation in value, would enable us to maximize long-term stockholder value.

Partnerships

• We also may enter into arrangements with the seller or developer of a real estate investment whereby the seller or developer agrees that if, during a stated period, the real estate investment does not generate specified cash flows, the seller or developer will pay us cash in an amount necessary to reach the specified cash flows level, subject in some cases to negotiated dollar limitations.

Legal & Regulatory Risks (Item 1A, quoted)

• Our business, tenants, residents and operators may face litigation and experience rising liability and insurance costs, which may materially and adversely affect us.
• The healthcare industry is heavily regulated, and new laws or regulations, changes to existing laws or regulations, loss of licensure or failure to obtain licensure could result in the inability of our tenants to make rent payments to us or adversely affect our operators' ability to operate facilities held in RIDEA structures.
• We may be subject to adverse legislative or regulatory tax changes that could increase our tax liability or reduce our operating flexibility.
• The healthcare industry is heavily regulated and new laws or regulations, changes to existing laws or regulations, loss of licensure or failure to obtain licensure could result in the inability of our tenants to make rent payments to us or adversely affect our operators' ability to operate facilities held in RIDEA structures.

Source: SEC EDGAR 10-K, official filing. Curated by Nexqual.

Data source: Nexqual — market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: October 29, 2026 at 20:30 UTC. This page is informational and not investment advice.

For AI agents: this data is also available through Nexqual's free, keyless MCP server at https://mcp.nexqual.com/mcp; every result includes source_url, as_of and cite_as. More: nexqual.com/agents · llms.txt